Technical Analysis for TEVVF - Teva Pharmaceutical Industries Limited

Grade Last Price % Change Price Change
grade C 355.0 -2.77% -10.1100
TEVVF closed down 2.77 percent on Friday, December 14, 2018, on 27 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical TEVVF trend table...

Date Alert Name Type % Chg
Older signals for TEVVF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides specialty medicines for use in central nervous system and respiratory indications. Its products in the central nervous system area comprise Copaxone for the treatment of relapsing forms of MS; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. The company has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Health RTT Pharmaceutical Industry Pharmaceutical Medication Active Pharmaceutical Ingredients Asthma Chronic Obstructive Pulmonary Disease Ms Science And Technology In Israel Treatment Of Asthma And Chronic Obstructive Pulmonary Disease Tardive Dyskinesia Chorea Deutetrabenazine Glatiramer Acetate Huntington Disease Pharmac Sterile Products Teva Teva Pharmaceutical Industries

Is TEVVF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 471.0
52 Week Low 286.75
Average Volume 81,565
200-Day Moving Average 397.6364
50-Day Moving Average 400.6262
20-Day Moving Average 393.1886
10-Day Moving Average 374.3531
Average True Range 25.5355
ADX 37.37
+DI 10.4895
-DI 36.8226
Chandelier Exit (Long, 3 ATRs ) 365.3935
Chandelier Exit (Short, 3 ATRs ) 386.6065
Upper Bollinger Band 441.0134
Lower Bollinger Band 345.3638
Percent B (%b) 0.1
BandWidth 24.3266
MACD Line -14.4599
MACD Signal Line -9.4247
MACD Histogram -5.0352
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 431.4250
Resistance 3 (R3) 425.2667 393.6333 418.6875
Resistance 2 (R2) 393.6333 374.1704 396.7125 414.4383
Resistance 1 (R1) 374.3167 362.1462 358.5000 380.4750 410.1941
Pivot Point 342.6833 342.6833 334.7750 345.7625 342.6833
Support 1 (S1) 323.3667 323.2204 307.5500 329.5250 299.8059
Support 2 (S2) 291.7333 311.1962 294.8125 295.5617
Support 3 (S3) 272.4167 291.7333 291.3125
Support 4 (S4) 278.5750